Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF 4,4'-BIPYRIDINE BRIDGED TETRANUCLEAR PLATINUM COMPLEX IN PREPARATION OF ANTI-TELOMERASE NEGATIVE TUMOUR MEDICINE
Document Type and Number:
WIPO Patent Application WO/2016/127681
Kind Code:
A1
Abstract:
Disclosed is a use of a 4,4'-bipyridine bridged tetranuclear platinum complex in the preparation of an anti-telomerase negative tumour medicine, wherein proliferation of telomerase negative tumour cells can be effectively inhibited.

Inventors:
ZHAO YONG (CN)
ZHENG XIAOHUI (CN)
MAO ZONGWAN (CN)
XIA LIXIN (CN)
Application Number:
CN2015/094908
Publication Date:
August 18, 2016
Filing Date:
November 18, 2015
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SUN YAT-SEN UNIV (510275, CN)
International Classes:
C07F15/00; A61K31/555; A61P35/00
Domestic Patent References:
WO2012155559A12012-11-22
Other References:
XIAOHUI ZHENG ET AL., PT (II) SQUARES AS SELECTIVE AND EFFECTIVE HUMAN TELOMERIC G-QUADRUPLEX BINDERS AND POTENTIAL CANCER THERAPEUTIES DALTON TRANSACTIONS, 31 December 2012 (2012-12-31), pages 11807 - 11812
Attorney, Agent or Firm:
GUANGZHOU SINO PATENT & TRADEMARK AGENT CO.,LTD. (510095, CN)
广州新诺专利商标事务所有限公司 (510095, CN)
Download PDF: